{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-010865","form_type":"8-K","ticker":"ARVN","cik":"0001655759","company_name":"ARVINAS, INC.","filed_at":"2026-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.781384+00:00","generated_at":"2026-05-16T00:49:36.047745+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Arvinas reports Q4/FY2025 cash of $685.4M, appoints new CEO Randy Teel, PDUFA date June 2026","bullets":["Cash and equivalents $685.4M at Dec 31, 2025 (vs $1,039.4M in 2024); runway into 2H 2028.","GAAP R&D expenses $285.2M for FY2025, down from $348.2M in FY2024.","Randy Teel, Ph.D., appointed President, CEO, and Director; John Houston retired but remains on Board.","First NDA submitted for vepdegestrant (PROTAC ER degrader); PDUFA action date June 5, 2026.","Repurchased $91.9M of common stock under buyback program in FY2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-010865","json":"https://secwatch.observer/filing/0001628280-26-010865.json","markdown":"https://secwatch.observer/filing/0001628280-26-010865.md","text":"https://secwatch.observer/filing/0001628280-26-010865.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1655759/000162828026010865/0001628280-26-010865-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1655759/000162828026010865/arvn-20260224.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T00:49:36.047745+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}